AbCellera Biologics acquires Trianni Inc. for $90 million
VANCOUVER: AbCellera Biologics has acquired Trianni Inc. in an all-cash transaction valued at US$90 million, a news release said. The acquisition deepens AbCellera’s technology stack with a suite of genetically engineered mice for generating diverse panels of human antibodies with…